Secondary hematologic malignancies associated with temozolomide (TMZ) in patients with glioma.

被引：1
|
作者：
Momota, H.
Narita, Y.
Miyakita, Y.
Shibui, S.
机构：
[1] Nagoya Univ, Nagoya, Aichi 4648601, Japan
[2] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2046
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Secondary hematological malignancies associated with temozolomide in patients with glioma
    Momota, Hiroyuki
    Narita, Yoshitaka
    Miyakita, Yasuji
    Shibui, Soichiro
    NEURO-ONCOLOGY, 2013, 15 (10) : 1445 - 1450
  • [2] Hematologic adverse events associated with temozolomide (TMZ)
    Villano, J. L.
    Letarte, N.
    Yu, J. M.
    Shakir, A. R.
    Bressler, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] TEMOZOLOMIDE (TMZ) IN HIGH GRADE GLIOMA PATIENTS: OUR EXPERIENCE
    Alafaci, Elisabetta
    Adamo, Vincenzo
    Scandurra, Giuseppa
    Altavilla, Giuseppe
    La Torre, Francesco
    Delia, Pietro
    Pergolizzi, Stefano
    Alafaci, Concetta
    d'Avella, Domenico
    Salpietro, Francesco
    Tomasello, Francesco
    ANNALS OF ONCOLOGY, 2004, 15 : 85 - 85
  • [4] Pharmacoepidemiology of myelotoxicity (TOX) with temozolomide (TMZ) in malignant glioma patients
    Armstrong, T. S.
    Cao, Y.
    Vera, E.
    Scheurer, M. E.
    Manning, R.
    Okcu, M. F.
    Bondy, M.
    Gilbert, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Effect of temozolomide chronotherapy in patients with high-grade glioma.
    Atluri, Himachandana
    Campian, Jian Li
    Talcott, Grayson
    Meyer, Melissa
    Slat, Emily
    Rubin, Joshua
    Huang, Jiayi
    Chheda, Milan G.
    Johanns, Tanner Michael
    Tao, Yu
    Govindan, Ashwin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Temozolomide (TMZ) and radiation (XRT) for aggressive pediatric malignancies
    Loh, KC
    Willett, J
    Meltzer, H
    Roberts, W
    Kerlin, B
    Kadota, R
    Levy, M
    Geddis, A
    Schiff, D
    Martin, L
    Yu, A
    Kung, F
    Spear, NA
    NEURO-ONCOLOGY, 2004, 6 (04) : 461 - 462
  • [7] Concurrent temozolomide and radiation as the initial treatment for anaplastic glioma.
    Tham, C. K.
    See, S.
    Tan, S. H.
    Ng, W. H.
    Lim, K. H. C.
    Thomas, J.
    Chua, E. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Temozolomide in the treatment of progressive low-grade glioma.
    Silva, NS
    Paes, V
    Galeana, J
    Pascalicchio, AP
    Galväo, C
    Cavalheiro, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 806S - 806S
  • [9] A phase I study of cloretazine® and temozolomide in patients with hematologic malignancies.
    Rizzieri, David A.
    Tse, William
    Khan, Khuda D.
    Advani, Anjali
    Donze, Jon
    Karsten, Verena
    Geller, Robert B.
    Gerson, Stanton L.
    BLOOD, 2006, 108 (11) : 557A - 558A
  • [10] Phase I study of procaspase activating compound-1 (PAC-1) in combination with temozolomide (TMZ) for the treatment of recurrent malignant glioma.
    Nicholas, Martin Kelly
    Holdhoff, Matthias
    Peterson, Richard A.
    Danciu, Oana Cristina
    Tarasow, Theodore M.
    Hergenrother, Paul J.
    Dudek, Arkadiusz Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345